Temsamani Karim Saad 4
4 · Cardlytics, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Temsamani Karim Saad
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-01+84,078→ 361,813 total - Sale
Common Stock
2024-03-04$7.89/sh−34,515$272,323→ 327,298 total - Exercise/Conversion
Restricted Stock Unit
2024-03-01−84,078→ 840,789 total→ Common Stock (84,078 underlying)
Footnotes (4)
- [F1]Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
- [F2]Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on March 1, 2024. The Reporting Person did not sell shares for any other purpose.
- [F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.66 to $8.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
- [F4]25% of the RSUs vested on September 1, 2023, with the remaining 75% having vested or vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.